Skip to main content

Table 2 Trial assessment schedule

From: The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial

 

Enrollment

Treatment

Post-TIPS follow-up

Evaluation/examination

≤14 days before randomization

D0

D1

D2

M1

M3

M6

M12

M18

M24

Informed consent

×

         

Demographics

×

         

Medical History

×

         

Enhanced abdominal CT

×

  

×

 

×

 

×

 

×

Ultrasound Elastography

×

  

×

×

×

×

×

×

×

Upper gastrointestinal endoscopy

×

   

×

×

×

×

×

×

Hematologya

×

×

×

 

×

×

×

×

×

×

Biochemistryb

×

 

×

 

×

×

×

×

×

×

Serial ammonia concentration

×

 

×

 

×

×

×

×

×

×

Tumor markersc

×

 

×

 

×

×

×

×

×

×

HBV-DNA

×

 

×

 

×

×

×

×

×

×

Child-Pugh

×

 

×

 

×

×

×

×

×

×

MELDd

×

 

×

 

×

×

×

×

×

×

ECOGe

×

×

×

×

×

×

×

×

×

×

HE assessmentf

×

×

×

×

×

×

×

×

×

×

Adverse events

×

×

×

×

×

×

×

×

×

×

Survival

×

×

×

×

×

×

×

×

×

×

  1. aMeasurement of red blood cells, hemoglobin, white blood cells, absolute neutrophils and absolute lymphocytes,and platelets
  2. bMeasurement of total bilirubin, direct and indirect bilirubin, albumin, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, glutamine transferase, urea nitrogen, serum creatinine, potassium, sodium, prothrombin time, INR, and D-dimer
  3. cMeasurement of AFP, CEA, and CA-199
  4. dModel for End-stage Liver Disease scores
  5. eEastern Cooperative Oncology Group
  6. fMeasured by Stroop Test and clinical examination